Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Identification of the cell targets important for propolis-induced cell death in Candida albicans.

de Castro PA, Bom VL, Brown NA, de Almeida RS, Ramalho LN, Savoldi M, Goldman MH, Berretta AA, Goldman GH.

Fungal Genet Biol. 2013 Nov;60:74-86. doi: 10.1016/j.fgb.2013.07.001. Epub 2013 Jul 13.

2.

Propolis increases neutrophils response against Candida albicans through the increase of reactive oxygen species.

Alves de Lima NC, Ratti BA, Souza Bonfim Mendonça P, Murata G, Araujo Pereira RR, Nakamura CV, Lopes Consolaro ME, Estivalet Svidzinski TI, Hatanaka E, Bruschi ML, Oliveira Silva S.

Future Microbiol. 2018 Feb;13:221-230. doi: 10.2217/fmb-2017-0112. Epub 2018 Jan 5.

PMID:
29302986
3.

Effect of propolis on virulence factors of Candida albicans.

D'Auria FD, Tecca M, Scazzocchio F, Renzini V, Strippoli V.

J Chemother. 2003 Oct;15(5):454-60.

PMID:
14598937
4.

Antifungal activity and influence of propolis against germ tube formation as a critical virulence attribute by clinical isolates of Candida albicans.

Haghdoost NS, Salehi TZ, Khosravi A, Sharifzadeh A.

J Mycol Med. 2016 Dec;26(4):298-305. doi: 10.1016/j.mycmed.2015.11.004. Epub 2016 Oct 24.

PMID:
27789229
5.

ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis.

Luna-Tapia A, Peters BM, Eberle KE, Kerns ME, Foster TP, Marrero L, Noverr MC, Fidel PL Jr, Palmer GE.

Eukaryot Cell. 2015 Oct;14(10):1006-16. doi: 10.1128/EC.00116-15. Epub 2015 Jul 31.

6.
7.

Antifungal activity of propolis extract against yeasts isolated from vaginal exudates.

Dalben-Dota KF, Faria MG, Bruschi ML, Pelloso SM, Lopes-Consolaro ME, Svidzinski TI.

J Altern Complement Med. 2010 Mar;16(3):285-90. doi: 10.1089/acm.2009.0281.

PMID:
20192913
8.

Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.

Martinez A, Ferrer S, Santos I, Jimenez E, Sparrowe J, Regadera J, De Las Heras FG, Gargallo-Viola D.

Antimicrob Agents Chemother. 2001 Dec;45(12):3304-9.

9.

Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis.

Rossi DC, Muñoz JE, Carvalho DD, Belmonte R, Faintuch B, Borelli P, Miranda A, Taborda CP, Daffre S.

BMC Microbiol. 2012 Mar 6;12:28. doi: 10.1186/1471-2180-12-28.

10.

Antibacterial and antifungal activity of Iranian propolis against Staphylococcus aureus and Candida albicans.

Ghasem YB, Ownagh A, Hasanloei M.

Pak J Biol Sci. 2007 Apr 15;10(8):1343-5.

PMID:
19069941
11.

[Effect of Mexican propolis extracts from Apis mellifera on Candida albicans in vitro growth].

Quintero-Mora ML, Londoño-Orozco A, Hernández-Hernández F, Manzano-Gayosso P, López-Martínez R, Soto-Zárate CI, Carrillo-Miranda L, Penieres-Carrillo G, García-Tovar CG, Cruz-Sánchez TA.

Rev Iberoam Micol. 2008 Mar;25(1):22-6. Spanish.

12.

Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.

Liu XP, Fan SR, Bai FY, Li J, Liao QP.

Mycoses. 2009 Jan;52(1):24-8. doi: 10.1111/j.1439-0507.2008.01539.x. Epub 2008 May 21.

PMID:
18498300
13.

Antifungal activity of propolis on different species of Candida.

Ota C, Unterkircher C, Fantinato V, Shimizu MT.

Mycoses. 2001 Nov;44(9-10):375-8.

PMID:
11766101
14.

Immunomodulatory efficacy of ethanol extract of propolis on tumor-bearing mice with disseminated candidiasis.

Khosravi AR, Shokri H, Darvishi S, Taghavi M.

J Mycol Med. 2014 Dec;24(4):e143-8. doi: 10.1016/j.mycmed.2014.05.002. Epub 2014 Oct 22.

PMID:
25442915
15.

Identification of inhibitors of yeast-to-hyphae transition in Candida albicans by a reporter screening assay.

Heintz-Buschart A, Eickhoff H, Hohn E, Bilitewski U.

J Biotechnol. 2013 Mar 10;164(1):137-42. doi: 10.1016/j.jbiotec.2012.12.004. Epub 2012 Dec 20.

PMID:
23262131
16.

Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.

Goswami D, Goswami R, Banerjee U, Dadhwal V, Miglani S, Lattif AA, Kochupillai N.

J Infect. 2006 Feb;52(2):111-7.

PMID:
15908007
17.

Preparation and characterization of mucoadhesive thermoresponsive systems containing propolis for the treatment of vulvovaginal candidiasis.

Pereira RR, Ribeiro Godoy JS, Stivalet Svidzinski TI, Bruschi ML.

J Pharm Sci. 2013 Apr;102(4):1222-34. doi: 10.1002/jps.23451. Epub 2013 Jan 18.

PMID:
23334938
18.

Efficacy of Histatin5 in a murine model of vulvovaginal candidiasis caused by Candida albicans.

Liao H, Liu S, Wang H, Su H, Liu Z.

Pathog Dis. 2017 Aug 31;75(6). doi: 10.1093/femspd/ftx072.

PMID:
28645176
19.

The synthetic melanocortin (CKPV)2 exerts anti-fungal and anti-inflammatory effects against Candida albicans vaginitis via inducing macrophage M2 polarization.

Ji HX, Zou YL, Duan JJ, Jia ZR, Li XJ, Wang Z, Li L, Li YW, Liu GY, Tong MQ, Li XY, Zhang GH, Dai XR, He L, Li ZY, Cao C, Yang Y.

PLoS One. 2013;8(2):e56004. doi: 10.1371/journal.pone.0056004. Epub 2013 Feb 14.

20.

Pulsatilla decoction inhibits Candida albicans proliferation and adhesion in a mouse model of vulvovaginal candidiasis via the Dectin-1 signaling pathway.

Yang L, Wu H, Qiu W, Guo L, Du X, Yu Q, Gao J, Luo S.

J Ethnopharmacol. 2018 Sep 15;223:51-62. doi: 10.1016/j.jep.2018.05.018. Epub 2018 May 26.

PMID:
29775695

Supplemental Content

Support Center